Madison Realty Capital Originates $345 Million Loan for St. Regis Residences on Boston Waterfront

January 13, 2022

NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on debt and equity investment strategies, today announced that it has originated a $345 million loan to Cronin Development for the completion of a 22-story, 114-unit residential and retail condominium development at 150 Seaport Boulevard […]

Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants and Outlines Initiatives to Address Omicron

January 13, 2022

Recent Publications by Several Independent Laboratories Show ADG20 Has Neutralizing Activity with Potency Comparable to Other Antibodies that Retain Activity Against Omicron Multiple Efforts Underway to Address Omicron and Potential Future SARS-CoV-2 Variants WALTHAM, Mass., Jan. 12, 2022 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development […]

Madison Realty Capital Raises More Than $2 Billion For Madison Realty Capital Debt Fund V

January 11, 2022

NEW YORK, Jan. 11, 2022 (GLOBE NEWSWIRE) — Madison Realty Capital (“Madison”) today announced the final close of Madison Realty Capital Debt Fund V LP (“Fund V”), raising $2.08 billion in equity commitments, exceeding the fund’s $1.75 billion target. Fund V received significant support from existing investors as approximately 70% of the institutional LPs in […]

Following EFSA Ban of Food Additive Titanium Dioxide (TiO2), Blue California Launches Clean-label Food Grade Whitening Agents as Alternatives

January 11, 2022

Rancho Santa Margarita, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — Following food authority EFSA’s ban of food additive titanium dioxide (TiO2), Blue California, the producer of natural science-based ingredients, launched novel food-grade whitening agents as a clean-label alternative to replacing potential health risk white colorant titanium dioxide. “Brands that seek to replace the titanium dioxide […]

Zoom Becomes the First Video Communications Client to Attain Common Criteria Certification

January 11, 2022

Issued by the German Federal Office for Information Security, the Certification Reinforces Zoom’s Commitment to Security SAN JOSE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today announced that Zoom Meeting Client version 5.6.6 has become the first video communications client to attain certification for Common Criteria Evaluation Assurance Level […]

Zenas BioPharma Appoints Dr. John Orloff to Board of Directors

January 6, 2022

BOSTON and SHANGHAI, China, Jan. 06, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and delivery of immune-based therapies, today announced the appointment of John Orloff, MD to its Board of Directors. Dr. Orloff joins the Zenas Board with over 25 years of experience successfully […]

Conagen Successfully Develops Antioxidant Kaempferol by Precision Fermentation

January 5, 2022

Bedford, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — Conagen, the Massachusetts-based biotechnology innovator, announced the successful development of antioxidant kaempferol produced by state-of-the-art, proprietary, precision fermentation. As a biotechnology company specializing in developing commercially valuable molecules for its partners and clients, Conagen’s kaempferol enables brands in nutrition, beauty, and personal care products to adopt a […]

Harris acquires i2 product portfolio from IBM

January 5, 2022

OTTAWA, Ontario and CAMBRIDGE, United Kingdom, Jan. 04, 2022 (GLOBE NEWSWIRE) — Harris, a global vertical market software provider, has acquired the i2 intelligence analysis product portfolio of IBM, including the i2 Analyst’s Notebook, i2 Enterprise Insight Analysis (EIA) and i2 iBase platforms. The acquisition positions Harris to further deliver mission-critical applications for national defense, […]